Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian families.

Calabresi L, Pisciotta L, Costantin A, Frigerio I, Eberini I, Alessandrini P, Arca M, Bon GB, Boscutti G, Busnach G, Frascà G, Gesualdo L, Gigante M, Lupattelli G, Montali A, Pizzolitto S, Rabbone I, Rolleri M, Ruotolo G, Sampietro T, Sessa A, Vaudo G, Cantafora A, Veglia F, Calandra S, Bertolini S, Franceschini G.

Arterioscler Thromb Vasc Biol. 2005 Sep;25(9):1972-8.

2.

[LCAT (lecithin:cholesterol acyltransferase)].

Kinoshita M, Teramoto T.

Rinsho Byori. 2001 Nov;Suppl 116:125-30. Review. Japanese.

PMID:
11797372
3.
4.

[Molecular defects in familial LCAT deficiency].

Bujo H, Saito Y.

Nihon Rinsho. 1993 Feb;51(2):482-7. Review. Japanese.

PMID:
8464161
5.

A review on lecithin:cholesterol acyltransferase deficiency.

Saeedi R, Li M, Frohlich J.

Clin Biochem. 2015 May;48(7-8):472-5. doi: 10.1016/j.clinbiochem.2014.08.014. Review.

PMID:
25172171
6.

Lecithin-cholesterol acyltransferase (LCAT) deficiency without mutations in the coding sequence: a case report and literature review.

Shoji K, Morita H, Ishigaki Y, Rivard CJ, Takayasu M, Nakayama K, Nakayama T, Inoue Y, Ayaki M, Yoshimura A.

Clin Nephrol. 2011 Oct;76(4):323-8. Review.

PMID:
21955868
7.

Homozygous lecithin:cholesterol acyltransferase (LCAT) deficiency due to a new loss of function mutation and review of the literature.

Roshan B, Ganda OP, Desilva R, Ganim RB, Ward E, Haessler SD, Polisecki EY, Asztalos BF, Schaefer EJ.

J Clin Lipidol. 2011 Nov-Dec;5(6):493-9. doi: 10.1016/j.jacl.2011.07.002. Review.

8.

[Familial LCAT deficiency].

Kinoshita M.

Nihon Rinsho. 1994 Dec;52(12):3210-5. Review. Japanese.

PMID:
7853712
9.
10.

The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes.

Kuivenhoven JA, Pritchard H, Hill J, Frohlich J, Assmann G, Kastelein J.

J Lipid Res. 1997 Feb;38(2):191-205. Review.

11.

[LCAT deficiency: a nephrological diagnosis].

Boscutti G, Calabresi L, Pizzolitto S, Boer E, Bosco M, Mattei PL, Martone M, Milutinovic N, Berbecar D, Beltram E, Franceschini G.

G Ital Nefrol. 2011 Jul-Aug;28(4):369-82. Review. Italian.

PMID:
21809306
12.

Familial LCAT deficiency and fish-eye disease.

McIntyre N.

J Inherit Metab Dis. 1988;11 Suppl 1:45-56. Review.

PMID:
3141686
13.

Two novel molecular defects in the LCAT gene are associated with fish eye disease.

Kuivenhoven JA, Stalenhoef AF, Hill JS, Demacker PN, Errami A, Kastelein JJ, Pritchard PH.

Arterioscler Thromb Vasc Biol. 1996 Feb;16(2):294-303. Review.

14.

Genetic lecithin:cholesterol acyltransferase deficiency and cardiovascular disease.

Calabresi L, Simonelli S, Gomaraschi M, Franceschini G.

Atherosclerosis. 2012 Jun;222(2):299-306. doi: 10.1016/j.atherosclerosis.2011.11.034. Review.

PMID:
22189200
15.

Advances in understanding of the role of lecithin cholesterol acyltransferase (LCAT) in cholesterol transport.

Dobiásová M, Frohlich JJ.

Clin Chim Acta. 1999 Aug;286(1-2):257-71. Review.

PMID:
10511297
16.

Lecithin:cholesterol acyltransferase: old friend or foe in atherosclerosis?

Kunnen S, Van Eck M.

J Lipid Res. 2012 Sep;53(9):1783-99. doi: 10.1194/jlr.R024513. Review.

17.

Lecithin:cholesterol acyltransferase, high-density lipoproteins, and atheroprotection in humans.

Calabresi L, Franceschini G.

Trends Cardiovasc Med. 2010 Feb;20(2):50-3. doi: 10.1016/j.tcm.2010.03.007. Review.

PMID:
20656215
18.

Characteristic kidney pathology, gene abnormality and treatments in LCAT deficiency.

Hirashio S, Ueno T, Naito T, Masaki T.

Clin Exp Nephrol. 2014 Apr;18(2):189-93. doi: 10.1007/s10157-013-0895-4. Review.

PMID:
24174160
19.

Very low levels of HDL cholesterol and atherosclerosis, a variable relationship--a review of LCAT deficiency.

Savel J, Lafitte M, Pucheu Y, Pradeau V, Tabarin A, Couffinhal T.

Vasc Health Risk Manag. 2012;8:357-61. doi: 10.2147/VHRM.S29985. Review.

20.

Lecithin cholesterol acyltransferase: an anti- or pro-atherogenic factor?

Rousset X, Shamburek R, Vaisman B, Amar M, Remaley AT.

Curr Atheroscler Rep. 2011 Jun;13(3):249-56. doi: 10.1007/s11883-011-0171-6. Review.

Items per page

Supplemental Content

Support Center